P1-020: Structural brain changes mediate the association between cardiovascular risk burden and cognitive decline in old age: A population-based study

2015 ◽  
Vol 11 (7S_Part_7) ◽  
pp. P344-P344
Author(s):  
Rui Wang ◽  
Laura Fratiglioni ◽  
Grégoria Kalpouzos ◽  
Martin Lövdén ◽  
Erika Jonsson Laukka ◽  
...  
2016 ◽  
Vol 13 (3) ◽  
pp. 247-256 ◽  
Author(s):  
Rui Wang ◽  
Laura Fratiglioni ◽  
Grégoria Kalpouzos ◽  
Martin Lövdén ◽  
Erika J. Laukka ◽  
...  

2016 ◽  
Vol 1 (1) ◽  
pp. 1-7 ◽  
Author(s):  
Lisette A. Zuurbier ◽  
Meike W. Vernooij ◽  
Annemarie I. Luik ◽  
Desana Kocevska ◽  
Albert Hofman ◽  
...  

2015 ◽  
Vol 11 (7S_Part_3) ◽  
pp. P134-P134
Author(s):  
Chengxuan Qiu ◽  
Anna Laveskog ◽  
Rui Wang ◽  
Lena Bronge ◽  
Lars-Olof Wahlund ◽  
...  

BMJ ◽  
2004 ◽  
Vol 329 (7471) ◽  
pp. 881 ◽  
Author(s):  
David J Vinkers ◽  
Jacobijn Gussekloo ◽  
Max L Stek ◽  
Rudi G J Westendorp ◽  
Roos C van der Mast

Abstract Objective To examine the temporal relation between depression and cognitive impairment in old age. Design Prospective, population based study with four years of follow up. Setting City of Leiden, the Netherlands. Participants 500 people aged 85 years at recruitment. Main outcome measures Annual assessments of depressive symptoms (15 item geriatric depression scale), global cognitive function (mini-mental state examination), attention (Stroop test), processing speed (letter digit coding test), and immediate and delayed recall (12 word learning test). Results At 85 years old, participants' depressive symptoms and cognitive impairment were highly significantly correlated (P < 0.001). During follow up, an accelerated annual increase of depressive symptoms was associated with impaired attention (0.08 points (95% confidence interval 0.01 to 0.16)), immediate recall (0.17 points (0.09 to 0.25)), and delayed recall (0.10 points (0.02 to 0.18)) at baseline. In contrast, depressive symptoms at baseline were not related to an accelerated cognitive decline during follow up (P > 0.05). Conclusion Caregivers should be aware of the development of depressive symptoms when cognitive impairment is present. However, the presence of depression only does not increase the risk of cognitive decline.


2019 ◽  
Vol 15 ◽  
pp. P832-P832
Author(s):  
Ya Gao ◽  
Rui Wang ◽  
Yajun Liang ◽  
Giulia Grande ◽  
Roberto Monastero ◽  
...  

2019 ◽  
Vol 64 ◽  
pp. S275-S276
Author(s):  
S. Kim ◽  
H.R. Nam ◽  
R.E. Kim ◽  
H.M. Ahn ◽  
S.K. Lee ◽  
...  

2020 ◽  
Vol 75 (20) ◽  
pp. 2525-2534 ◽  
Author(s):  
Ruixue Song ◽  
Hui Xu ◽  
Christina S. Dintica ◽  
Kuan-Yu Pan ◽  
Xiuying Qi ◽  
...  

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
M Chlabicz ◽  
J Jamolkowski ◽  
W Laguna ◽  
P Sowa ◽  
M Paniczko ◽  
...  

Abstract Funding Acknowledgements Type of funding sources: Public Institution(s). Main funding source(s): Medical University of Bialystok, Poland Background Cardiovascular disease (CVD) is a major, worldwide problem and remain the dominant cause of premature mortality in the word. Simultaneously the metabolic syndrome is a growing problem. The aim of this study was to investigate the cardiometabolic profile among cardiovascular risk classes, and to estimate CV risk using various calculators. Methods The longitudinal, population-based study, was conducted in 2017-2020. A total of 931 individuals aged 20-79 were included. Anthropometric and biochemical profiles were measured according to a standardized protocols. The study population was divided into CV risk classes according to the latest recommendation. Comparisons variables between subgroups were conducted using Dwass-Steele-Critchlow-Fligner test. To estimate CV risk were used: the  Systematic Coronary Risk Estimation system, Framingham Risk Score and LIFEtime-perspective model for individualizing CardioVascular Disease prevention strategies in apparently healthy people (LIFE-CVD). Results The mean age was 49.1± 15.5 years, 43.2% were male. Percentages of low-risk, moderate-risk, high-risk and very-high CV risk were 46.1%, 22.8%, 13.5%, 17.6%, respectively. Most of the analyzed anthropometric, body composition and laboratory parameters did not differ between the moderate and high CV risk participants, whereas the low risk group differed significantly. In the moderate and high-risk groups, abdominal distribution of adipose tissue dominated with significantly elevated parameters of insulin resistance. Interestingly, estimating lifetime risk of myocardial infarction, stroke or CV death using LIFE-CVD calculator yielded similar results in moderate and high CV risk classes. Conclusion The participants belonging to moderate and high CV risk classes have a very similar unfavorable cardiometabolic profile which may result in the similar lifetime CV risk. This may imply the need for more aggressive pharmacological and non-pharmacological management of CV risk factors in the moderate CV risk population. It would be advisable to consider combining the moderate and high risk classes into one high CV risk class, or it may be worth adding one of the parameters of abdominal fat distribution to the CV risk calculators as an expression of increased insulin resistance. Abstract Figure 1.


Sign in / Sign up

Export Citation Format

Share Document